OTC · NOUV
Nouveau Life Pharmaceuticals, Inc.
$0.00$0.00 (0.0%)
Nouveau Life Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · AVNY · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Manaris (2010) Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Montreal, Canada, Manaris (2010) Corp., established in 2000, operates internationally, distributing its products throughout the Americas, Europe, and Asia. Through its subsidiaries, the company is involved in the design, manufacturing, distribution, and marketing of optical components and modules, primarily serving the telecommunications, fiber laser, and optical sensor sectors. Furthermore, Manaris provides advanced instrumentation and integrated systems for monitoring industrial processes and for environmental surveillance across air, water, and soil. The corporation, formerly known as Avensys Corporation, officially adopted the Manaris (2010) Corp. name on August 23, 2010.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Nouveau Life Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Future Science Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.00 (-14.29%)
Frontera Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.78% below the high.
$0.00$0.00 (0.0%)
Astika Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.65% below the high.
$0.00$0.00 (0.0%)
National Healthcare Logistics Inc.’s quoted price sits in the lower half of its reported 52-week range, 20.0% below the high.
$0.00$0.00 (0.0%)
Pacific Vegas Global Strategies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Rainier Pacific Financial Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Green Street Capital Corp.: Financial Services · Asset Management.
